Neuroone(R) To Host Virtual Investor Webinar On Thursday, March 12, 2026 At 11:30 A.M. Eastern Time

2026-02-26 02:05:55

(MENAFN- EQS Group)

NeuroOne Medical Technologies / Key word(s): Financial
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time
26.02.2026 / 14:35 CET/CEST
The issuer is solely responsible for the content of this announcement.
EDEN PRAIRIE, MINN - February 26, 2026 (NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the“Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, announced today that it will hold a virtual investor webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time. Management will host the webinar to provide a corporate update, discuss the company's growth plans, and provide updates on its platform technologies, applications, and commercialization. A question-and-answer session will follow. To participate, please use the following information: Virtual Investor Webinar Date: Thursday, March 12, 2026
Time: 11:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 358063
Webcast: NMTC Virtual Investor Webinar Please join at least five minutes before the start of the call to ensure timely participation. A playback of the call will be available through Thursday, March 26, 2026. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 53635. A webcast replay will also be available using the webcast link above through Thursday, March 26, 2026. About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering combination diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery and spinal cord stimulation programs. For more information, visit nmtc1. IR Contact
MZ Group – MZ North America
... View the original release on
News Source: NeuroOne Medical Technologies
26.02.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language:	English
Company:	NeuroOne Medical Technologies


	United States
ISIN:	US64130M2098
EQS News ID:	2282306


End of News	EQS News Service

2282306 26.02.2026 CET/CEST

MENAFN26022026004691010666ID1110795292

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.